Bavarian Biotech Report 2011/2012 (7MB) - Bio M

ChemDiv, Inc.CROContact:Dr. Anna NieblingWaldstr. 22D-82049 PullachPhone: +49 (0) 89 74442700Fax: +49 (0) 89 79367571E-Mail: aniebling@chemdiv.comInternet: www.chemdiv.comKeywords: Clinical Research, Drug Development, Medicinal Chemistry, CNS,Pharmacology, Neurology, PainChemDiv, a global Contract Research Organization (CRO), offers IntegratedDiscovery outSource solutions that cover a complete range of disciplinesfrom medicinal chemistry to clinical development needed to bring newdrugs from target to market. With successful 20 years business record andover 500 research associates, the company puts forward unique translationalexpertise to help accelerate its partners R&D programs. ChemDiv providesProof of Concept data in less time and at a fraction of the costs typicallyseen in the industry with keeping the high quality standards, all of whichplays a critical role in mitigating risks associated with full scale clinicaldevelopment.ChromBios GmbHBIOTECH DNA/PROTEIN ANALYTICSContact:Dr. Andrea KoflerMühlenstr. 1D-83064 RaublingPhone: +49 (0) 8035 9849-28Fax: +49 (0) 8035 9849-30E-Mail: kofler@chrombios.comInternet: www.chrombios.comFounded in 1998, ChromBios is focused on the field of MolecularCytogenetics (fluorescence in situ hybridisation, FISH). The company‘s aimsare to provide service and products for chromosome analysis tailored to theneeds of the customers. We offer „FISH service“ such as chromosome analysiswith „chromosome painting“, mapping of clones, characterisation ofcancer cell lines and animal models in genome research. We especiallyfocus on multi colour karyotyping human tumour cells and other transformedcell lines (for example for patent applications). Chrombios also offersmulti colour chromosome painting of mouse cells to identify translocationsin mouse tumours and to characterise mouse ES cells. Apart from humanand mouse, we also provide service in the characterization of chromosomesfrom other animal model species including rat, hamster, cat, and variouslive stock animals.ChromoTek GmbHBIOTECH DNA/PROTEIN ANALYTICSContact:Dr. Marion JungAm Klopferspitz 19D-82152 MartinsriedPhone: +49 (0) 89 787973-10Fax: +49 (0) 89 787973-11E-Mail: info@chromotek.comInternet: www.chromotek.comKeywords: Clinical Diagnostics, Proteomics, Peptide/ProteinChromoTek GmbH, founded in 2008, is a biotech company focused on thediscovery and development of novel nanoprobes and cell based assays forbiomedical research and early drug development. During the last yearsChromoTek has developed innovative research tools including the GFP-Trap ® and RFP-Trap ® , two versatile pull-down reagents for biochemicalanalysis of fluorescent fusion proteins. In April 2011 ChromoTek successfullyintroduced its first cell based assay for early drug development, the U2OSCell Cycle Chromobody ® . This real-time High-Content Analysis (HCA) screeningassay enables to monitor the complete cell cycle in live cells for thefirst time. In addition ChromoTek developed the Fluorescent 2-Hybrid (F2H)-Assay to analyze protein-protein interactions in vivo in real time.48